Related Experiment Video
Updated: Jun 17, 2026
11:33
Isolation and Kv Channel Recordings in Murine Atrial and Ventricular Cardiomyocytes
Published on: March 12, 2013
Common genetic variants in ANK2 modulate QT interval: results from the KORA study
Kamil Sedlacek1, Klaus Stark, Shane R Cunha
1Klinik und Poliklinik für Innere Medizin II, Universitätsklinikum Regensburg, Regensburg, Germany.
Circulation. Cardiovascular Genetics
|December 25, 2009
Summary
Common genetic variants in the ankyrin-B gene (ANK2) influence QT interval duration. This discovery supports ankyrin-B's role in maintaining normal cardiac electrical activity and may impact arrhythmia susceptibility.
Area of Science:
- Cardiovascular genetics
- Cardiac electrophysiology
- Molecular cardiology
Background:
- QT interval variations can increase susceptibility to cardiac arrhythmias and sudden cardiac death.
- The ankyrin-B gene (ANK2) plays a crucial role in cardiac electrophysiology.
- Genetic variations in ANK2 were hypothesized to influence QT interval length.
Purpose of the Study:
- To investigate the association between common genetic variations in the ANK2 gene and QT interval duration.
- To explore the potential role of ANK2 in cardiac electrical activity.
Main Methods:
- Genotyping of 22 single-nucleotide polymorphisms (SNPs) in the ANK2 gene in 1188 participants (KORA S3 study).
- Replication study genotyped 6 SNPs in 3890 individuals (KORA S4 study).
- QT interval calculated using population-specific linear regression; expression analysis of ANK2 5' genomic region.
Main Results:
- The SNP rs6850768 in ANK2 significantly influenced QT interval duration in both study populations.
- Homozygotes for rs6850768 showed a QT interval shortening of 3.79 ms (KORA S3) and 2.94 ms (KORA S4).
- A common 2-locus haplotype (rs11098171-rs6850768) was associated with QT interval differences in both cohorts. Two novel ANK2 5' exons were identified near the variants.
Conclusions:
- Common genetic variants in the 5' genomic region of ANK2, near novel exons, affect QT interval length in the general population.
- These findings highlight the involvement of ankyrin-B in normal cardiac electric activity.
- The study provides genetic evidence linking ANK2 to QT interval regulation.
Related Concept Videos
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
01:20Antiepileptic Drugs: Potassium Channel Activators
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
01:05Single Nucleotide Polymorphisms-SNPs
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
01:12Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...
01:28Mechanism of Cardiac Arrhythmias
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.